Clinical Research

Improving patient care is the goal of Beacon Medical Group Clinical Research. As one of the area’s most comprehensive research centers, Beacon Clinical Research is involved in studies that are developing medications and devices for a variety of health conditions.

Clinical research trials conducted by Beacon Medical Group Clinical Research provide many benefits to not just our patients but to our local and global community as well. Participating in a clinical trial may help patients who are not responding to standard health care options. Patients receive more time and oversight from a physician both at their visit times and between visits as well.

On average, only one compound in 1,000 will actually make it to human testing. For those investigational products or devices that make it to market, the study process was long, going from a Phase 1 (healthy volunteers) to a Phase 5 (post-marketing safety). BMG Clinical Research has participated in all five study phases and has contributed to bringing new health care options to our community.

For more information or to apply for a clinical trial contact Pamela Wasielewski at 574.647.7883 or email pwasielewski@beaconhealthsystem.org.

You can view our current clinical trials below.

For Patients

What is a clinical trial?

The only way a new drug comes to market in the United States is after extensive human testing. A clinical or research trial is the process by which those human volunteers help contribute. Beacon Medical Group is our community’s resource for pharmaceutical and device research trials. To learn more about clinical trials, please visit ClinicalTrials.gov.

Who is eligible to participate in a clinical trial?

Volunteers are required to meet study criteria designed by the drug maker. The criteria make measurements of outcomes — good, bad or indifferent — possible.

Interested patients (volunteers) undergo a screening process that is tailored to that particular study protocol (study plan). The screening process begins the first time the individual speaks with the study nurse. The study nurse will ask a few key questions to see if they are eligible for the trial. Every study has a list of inclusion/exclusion criteria that a study volunteer (subject) has to meet in order to enroll in the study. If the volunteer meets the inclusion and is not disqualified by the exclusion criteria they will be scheduled for a visit with a research physician and study nurse. The first step at this initial visit is the informed consent process. The consent will contain a list of all known side effects and possible benefits of participating in the study. The consent also informs them that they are free to withdraw from the study at any time without any consequences. If the decision is made to participate in the study the subject may receive study procedures such as a physical examination and lab work.

All office visits, exams, labs, procedures and study drugs are provided at no cost to the volunteer. Volunteers are frequently reimbursed for travel and time commitment to the study.

Our Research Experience

We are proud to be in our second decade of performing clinical trials in our region. Care is provided by the physicians of Beacon Medical Group and an experienced staff of research registered nurses. Our staff also includes a regulatory and contracts specialist.

“Even if they don’t qualify for the trial, people walk away with great health information, free of charge, just for being a part of a clinical trial,” says Nicholas Straniero, MD, Medical Director of Beacon Medical Group Rheumatology. “A clinical trial is not something that every patient would be interested in, but for some, it’s reassuring for them to know that they’re advancing medicine not only for themselves, but for all future generations.”

We support a network of research sites to assure consistent quality, safety and compliance for the clinical trial process.

Areas of Clinical Research Expertise

  • Asthma
  • Cardiology
  • Diabetes (Type 2 diabetes)
  • Fibromyalgia
  • Gout
  • High blood pressure (hypertension)
  • Osteoarthritis
  • Psoriasis
  • Rheumatoid arthritis
  • Rosacea
  • Sprains and strains

Current Clinical Trials

Heart Failure Optimization Study (HF-OPT)

Primary Physician Investigator: John Kobayashi, MD

Contact: Toni Riehm | 547.647.6584 | triehm@beaconhealthsystem.org


A Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Injectafer® (Ferric Carboxymaltose) as Treatment for Heart Failure with Iron Deficiency

Primary Physician Investigator: John Kobayashi, MD

Contact: Toni Riehm | 547.647.6584 | triehm@beaconhealthsystem.org


Vigilant ObservatIon of Gliadel Wafer Implant Registry (VIGILANT)

Primary Physician Investigator: Joseph Schnittker, MD

Contact: Keri Christner | 574.294.8404 | kchristner@beaconhealthsystem.org


Safety and Effectiveness of Belimumab in Systemic Lupus Erythematosus Registry (SABLE)

Primary Physician Investigator: Nicholas Straniero, MD

Contact: Deborah Borkowski | 574.647.1593 | dborkowski@beaconhealthsystem.org


Empagliflozin Outcome Trial in Patients with Chronic Heart Failure with Preserved Ejection Fraction (EMPEROR-Preserved)

Primary Physician Investigator: John Kobayashi, MD

Contact: Toni Riehm | 547.647.6584 | triehm@beaconhealthsystem.org


Empagliflozin Outcome Trial in Patients with Chronic Heart Failure with Reduced Ejection Fraction (EMPEROR-Reduced)

Primary Physician Investigator: John Kobayashi, MD

Contact: Toni Riehm | 547.647.6584 | triehm@beaconhealthsystem.org


Long-term Antipsychotic Pediatric Safety Trial (LAPS)

Primary Physician Investigator: Ahmed Elmaadawi, MD

Contact: Toni Riehm | 547.647.6584 | triehm@beaconhealthsystem.org


Testing the Ability of JNJ-18038683 to Improve Cognition and Reduce Depressive Symptoms in Stable Bipolar Patients

Primary Physician Investigator: Ahmed Elmaadawi, MD

Contact: Deborah Borkowski | 574.647.6584 | dborkowski@beaconhealthsystem.org


A Study to Evaluate a Panel of Blood Biomarkers for Use in Patients Undergoing Evaluation for Lung Cancer, Onc-Ln-04

Primary Physician Investigator: Beniot Herbert, MD

Contact: Deborah Borkowski | 574.647.6584 | dborkowski@beaconhealthsystem.org


Evaluate the Sustained Response of NBI-98854 in Pediatric Subjects with Tourette Syndrome

See if your child may qualify

Primary Physician Investigator: Ahmed Elmaadawi, MD

Contact: Stephanie Pudio | 574.647.6584 | spudio@beaconhealthsystem.org